These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 15546116)

  • 1. Clinical trials of antifungal prophylaxis among patients undergoing surgery.
    Calandra T; Marchetti O
    Clin Infect Dis; 2004 Oct; 39 Suppl 4():S185-92. PubMed ID: 15546116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical trials of antifungal prophylaxis among patients in surgical intensive care units: concepts and considerations.
    Lipsett PA
    Clin Infect Dis; 2004 Oct; 39 Suppl 4():S193-9. PubMed ID: 15546117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antifungal prophylaxis with azoles in high-risk, surgical intensive care unit patients: a meta-analysis of randomized, placebo-controlled trials.
    Vardakas KZ; Samonis G; Michalopoulos A; Soteriades ES; Falagas ME
    Crit Care Med; 2006 Apr; 34(4):1216-24. PubMed ID: 16484923
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surgical critical care: fungal infections in surgical patients.
    Lipsett PA
    Crit Care Med; 2006 Sep; 34(9 Suppl):S215-24. PubMed ID: 16917426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Postoperative fungal infections.
    Eggimann P; Pittet D
    Surg Infect (Larchmt); 2006; 7 Suppl 2():S53-6. PubMed ID: 16895507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The epidemiology of Candida colonization and invasive candidiasis in a surgical intensive care unit where fluconazole prophylaxis is utilized: follow-up to a randomized clinical trial.
    Magill SS; Swoboda SM; Shields CE; Colantuoni EA; Fothergill AW; Merz WG; Lipsett PA; Hendrix CW
    Ann Surg; 2009 Apr; 249(4):657-65. PubMed ID: 19300221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How to improve the design of trials of antifungal prophylaxis among neutropenic adults with acute leukemia.
    Menichetti F
    Clin Infect Dis; 2004 Oct; 39 Suppl 4():S181-4. PubMed ID: 15546115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention and treatment of Candida infections in neonates.
    Chapman RL
    Semin Perinatol; 2007 Feb; 31(1):39-46. PubMed ID: 17317426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antifungal treatment strategies in high risk patients.
    Rüping MJ; Vehreschild JJ; Cornely OA
    Mycoses; 2008 Sep; 51 Suppl 2():46-51. PubMed ID: 18721331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Candida infections in the intensive care unit: epidemiology, risk factors and therapeutic strategies.
    Bassetti M; Righi E; Tumbarello M; Di Biagio A; Rosso R; Viscoli C
    Expert Rev Anti Infect Ther; 2006 Oct; 4(5):875-85. PubMed ID: 17140362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antifungal prophylaxis in solid-organ transplant recipients: considerations for clinical trial design.
    Singh N
    Clin Infect Dis; 2004 Oct; 39 Suppl 4():S200-6. PubMed ID: 15546118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluconazole for the management of invasive candidiasis: where do we stand after 15 years?
    Charlier C; Hart E; Lefort A; Ribaud P; Dromer F; Denning DW; Lortholary O
    J Antimicrob Chemother; 2006 Mar; 57(3):384-410. PubMed ID: 16449304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is Candida really a threat in the ICU?
    Blot S; Dimopoulos G; Rello J; Vogelaers D
    Curr Opin Crit Care; 2008 Oct; 14(5):600-4. PubMed ID: 18787456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Consensus statement on the management of invasive candidiasis in Intensive Care Units in the Asia-Pacific Region.
    Hsueh PR; Graybill JR; Playford EG; Watcharananan SP; Oh MD; Ja'alam K; Huang S; Nangia V; Kurup A; Padiglione AA
    Int J Antimicrob Agents; 2009 Sep; 34(3):205-9. PubMed ID: 19409759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recognition and prevention of nosocomial invasive fungal infections in the intensive care unit.
    Smith JA; Kauffman CA
    Crit Care Med; 2010 Aug; 38(8 Suppl):S380-7. PubMed ID: 20647796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Epidemiological features of Candida infections detected in intensive care units and risk factors affecting mortality].
    Acar A; Oncül O; Küçükardali Y; Ozyurt M; Haznedaroğlu T; Cavuşlu S
    Mikrobiyol Bul; 2008 Jul; 42(3):451-61. PubMed ID: 18822889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preemptive therapy in nonneutropenic patients with Candida infection using the Japanese guidelines.
    Tsuruta R; Mizuno H; Kaneko T; Oda Y; Kaneda K; Fujita M; Inoue T; Kasaoka S; Maekawa T
    Ann Pharmacother; 2007 Jul; 41(7):1137-43. PubMed ID: 17535843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The place for itraconazole in treatment.
    Maertens J; Boogaerts M
    J Antimicrob Chemother; 2005 Sep; 56 Suppl 1():i33-i38. PubMed ID: 16120632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiology, management, and risk factors for death of invasive Candida infections in critical care: a multicenter, prospective, observational study in France (2005-2006).
    Leroy O; Gangneux JP; Montravers P; Mira JP; Gouin F; Sollet JP; Carlet J; Reynes J; Rosenheim M; Regnier B; Lortholary O;
    Crit Care Med; 2009 May; 37(5):1612-8. PubMed ID: 19325476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antifungal prophylaxis for the prevention of neonatal candidiasis?
    O'Grady MJ; Dempsey EM
    Acta Paediatr; 2008 Apr; 97(4):430-3. PubMed ID: 18363952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.